- RecruitingPHASE1, PHASE2
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
This study is testing a new medicine, BMS-986470, for people with sickle cell disease and healthy volunteers. Researchers want to see if it's safe, how it works in the body, and if it helps with sickle cell symptoms. It's an early-stage study.
For: Anemia, Sickle Cell · Healthy VolunteersUnited States · Canada · France - Ongoing, recruitingTherapeutic use (Phase IV)
FAMODREP : Interest of Famotidine in Reducing Endothelial Expression of P-selectin in Children With Sickle Cell Disease: Pilot Study, Single-center, Prospective, Non-comparative
This study looks at whether a medicine called famotidine can help children with sickle cell disease. Researchers want to see if famotidine can reduce a specific marker in the blood that is linked to this condition. It's a small, early study to learn more.
For: Sickle Cell DiseaseFrance